Ablation‐Based Salvage Strategy at Disease Progression After Initial Disease Control With Atezolizumab/Bevacizumab in Hepatocellular Carcinoma
Year: 2026
Type: article
Study design: Observational Study
Source: Hepatology Research
DOI: 10.1111/hepr.70193
Authors: Kazuya Kariyama, Kazuhiro Nouso, Atsushi Hiraoka, Fujimasa Tada, Hideko Ohama, Hidenori Toyoda, Satoshi Yasuda, Toshifumi Tada, Kazunari Tanaka, Kunihiko Tsuji, Ei Itobayashi, Akemi Tsutsui, Koichi Takaguchi, Michitaka Imai, Toru Ishikawa, Takeshi Hatanaka, Yuki Kanayama, Satoru Kakizaki, Atsushi Naganuma, Yoshihide Ueda, Tomomitsu Matono, Hideyuki Tamai, Junpei Okamura, Hironori Tanaka, Yutaka Yata, Akiko Wakuta, Masatoshi Kudo, Takashi Kumada
Institutions: Okayama City Hospital, Ehime Prefectural Central Hospital, Ogaki Municipal Hospital, Kobe University, Teine Keijinkai Hospital, Asahi General Hospital, Kagawa Prefectural Central Hospital, Niigata Cancer Center Hospital, Saiseikai Niigata Daini Hospital, Gunma Saiseikai Maebashi Hospital, National Hospital Organization Takasaki General Medical Center, Kakogawa City Hospital Organization, Himeji Medical Center, Hyogo Prefectural Harima-Himeji General Medical Center, Wakayama Rosai Hospital, Takarazuka City Hospital, Hanwa Memorial Hospital, Kindai University, Gifu Kyoritsu University
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7160843556